search
Back to results

Examine the Effects of Mindfulness in Woman With a History of Child Adversity (EMMA)

Primary Purpose

Stress, Psychological Stress, Child Maltreatment

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Mindfulness and compassion-based practices; approximately 5-10 minutes two times/day
Mindful awareness and reporting of current thoughts and feelings, 2 times/day
Sponsored by
University of California, San Francisco
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Stress focused on measuring Mindfulness, Adverse childhood experiences, Stress, Depressive symptoms

Eligibility Criteria

30 Years - 50 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  1. female sex and gender identity (to control for sex and gender differences in stress responses and health outcomes)
  2. age 30-50 (to examine intervention effects on health outcomes in midlife)
  3. ≥2 Adverse Childhood Experiences (to ensure exposure to early life adversity)
  4. mild depressive symptoms (to allow for outcome improvements: PHQ-9 ≥ 5)
  5. having a smartphone (to access app-based assessments/interventions)

Exclusion Criteria:

  1. Non-English speaker or unable to provide informed consent
  2. Current regular mindfulness practice (exclude if >20 min/week)
  3. Major psychiatric condition, including psychosis/schizophrenia, bipolar disorder, post-traumatic stress disorder, eating disorders, alcohol/substance use, major depression (PHQ-9 ≥ 15), and self-harm or suicidal ideation
  4. Major medical conditions, including no history of coronary heart disease, diabetes, severe asthma or lung disease, autoimmune disorders, infectious disease, epilepsy, brain injury, endocrine disorders, diagnosis of cancer or chemotherapy or radiation in the past 10 years
  5. Free from medications known to affect the immune and endocrine systems with the exception of antidepressant medication and oral contraceptives
  6. Psychotherapy treatment permitted if stable (≥3 months)
  7. Current smoking and nicotine use
  8. Currently pregnant

Sites / Locations

  • University of California, San FranciscoRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Sham Comparator

Arm Label

Mindful Activity group

Mindful Awareness group

Arm Description

Participants complete mindfulness and compassion-based practices via the study app.

Participants monitor and report their thoughts and feelings via the study app.

Outcomes

Primary Outcome Measures

Acceptability of the intervention will be measured with an adapted version of the Treatment Acceptability Questionnaire (TAQ).
The Treatment Acceptability Questionnaire (TAQ) is a six-item scale assessing whether participants view their assigned intervention as acceptable, ethical, and effective. Items are rated on a 7-point Likert scale (e.g., 1 "very unacceptable" to 7 "very acceptable), with a possible score range from 6 to 42. Higher scores indicate better treatment acceptability and positive perceptions of the treatment. A total mean score of at least 24 will indicate sufficient acceptability of the intervention.
Feasibility, as indicated by numbers of participants screened (completed web-based screener and phone screener), eligible based on web-based screener and phone screener, consented, randomized to treatment, and retained at follow-up.
Feasibility outcomes will include: >70% of eligible participants (passed web-based and phone screener) will be consented, >70% of consented participants will pass further baseline screening procedures and will be randomized to treatment, >70% of participants who are randomized to treatment will be retained at follow-up. Reasons for ineligibility and drop out will also be assessed.
Adherence, as measured by the percentage of assigned and completed intervention group practices.
Completion of at least 50% of assigned intervention group practices (Ecological Momentary Assessments for Mindful Awareness group; mindfulness practices for Mindful Activity group) is considered acceptable.

Secondary Outcome Measures

Change in depressive symptoms, as measured by the total score on the 9-item Patient Health Questionnaire (PHQ-9).
The 9-item Patient Health Questionnaire (PHQ-9) has a total score scale range of 0 to 27, with higher values indicating more depressive symptoms.

Full Information

First Posted
February 10, 2022
Last Updated
November 17, 2022
Sponsor
University of California, San Francisco
Collaborators
National Institute on Aging (NIA)
search

1. Study Identification

Unique Protocol Identification Number
NCT05255380
Brief Title
Examine the Effects of Mindfulness in Woman With a History of Child Adversity
Acronym
EMMA
Official Title
Pilot Randomized Controlled Trial Examining the Effects of Daily Mindfulness in Woman With a History of Child Adversity
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Recruiting
Study Start Date
June 3, 2022 (Actual)
Primary Completion Date
September 2023 (Anticipated)
Study Completion Date
September 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of California, San Francisco
Collaborators
National Institute on Aging (NIA)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of this pilot Randomized Controlled Trial (RCT) is to test whether brief mindfulness-based practices will improve well-being and health in women (age 30-50) with a history of early life adversity. Following a baseline visit (remotely via Zoom), participants are randomized (50% probability) to either a Mindful Activity group or a Mindful Awareness group. In the Mindful Activity group, participants will complete brief (approximately 5-10 min) audio-guided mindfulness practices twice a day (morning and evening) for 8 weeks using the study app. This is followed by a brief survey about their current thoughts and feelings. In the Mindful Awareness group, participants are asked to be mindful (pay attention) to their thoughts and feelings twice a day (morning and evening) for 8 weeks using the study app. After the 8-week intervention period, all participants complete a follow-up visit (remotely). Primary goals of the pilot RCT are to test acceptability, feasibility, and adherence.
Detailed Description
The pilot Randomized Controlled Trial (RCT) randomly assigns midlife women (age 30-50) with a history of early life adversity to either a Mindful Activity group or a Mindful Awareness group to primarily test acceptability, feasibility, and adherence. Randomization will occur by chance at the end of the baseline visit. Participants randomized to the Mindful Activity group will receive 8 weeks of ecological momentary assessment and intervention sessions via the study app. Mindfulness-based interventions consist of mindfulness and compassion-based practices. For example, practices focus on the breath/body (e.g., 3-minute breathing space; compassionate body scan; five senses mediation), on increasing participants' inner resources (e.g., imaging a safe person or safe place), on reducing negative affect (e.g., self-compassionate and acceptance-based practices), or on increasing positive emotions (e.g., gratitude practice; metta practices). All interventions are audio-guided and approximately 5-10 minutes. Participants complete two mindfulness interventions/day (one in the morning; one in the evening). After completing a mindfulness-based intervention, participants will complete ecological momentary assessments of their current psychological stress states (e.g., stress appraisals, affect, perseverative cognitions, self-criticism, social connection) via the study app. Participants randomized to the Mindful Awareness group are instructed to be mindful (pay attention) to their current thoughts and feelings and complete ecological momentary assessments of their current psychological stress states (e.g., stress appraisals, affect, perseverative cognitions, self-criticism, social connection) twice/day (morning and evening) for 8 weeks via the study app. A trained research assistant will monitor participant adherence and address potential difficulties. All participants will complete assessments at baseline (pre-intervention) and post-intervention (after the 8-week intervention). Weekly measures of depressive symptoms are also obtained. The investigators plan to consent about 100 participants with the goal of having 70 eligible participants enrolled in the study (about 35 in each group).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stress, Psychological Stress, Child Maltreatment, Depressive Symptoms, Signs and Symptoms
Keywords
Mindfulness, Adverse childhood experiences, Stress, Depressive symptoms

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Participants are assigned to either a Mindful Activity group or a Mindful Awareness group. Randomization will occur by chance (50%) at the end of the baseline visit.
Masking
Investigator
Allocation
Randomized
Enrollment
70 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Mindful Activity group
Arm Type
Experimental
Arm Description
Participants complete mindfulness and compassion-based practices via the study app.
Arm Title
Mindful Awareness group
Arm Type
Sham Comparator
Arm Description
Participants monitor and report their thoughts and feelings via the study app.
Intervention Type
Behavioral
Intervention Name(s)
Mindfulness and compassion-based practices; approximately 5-10 minutes two times/day
Intervention Description
The app-based (audio-guided) interventions consist of mindfulness and compassion-based practices that are selected to maximize their effect on stress targets. Interventions include, for example, practices that focus on the breath/body (e.g., 3-minute breathing space; compassionate body scan; five senses mediation), on increasing participants' inner resources (e.g., imaging a safe person or safe place), on reducing negative affect (e.g., self-compassion and acceptance-based practices), or on increasing positive emotions (e.g., gratitude practice; metta practices).
Intervention Type
Behavioral
Intervention Name(s)
Mindful awareness and reporting of current thoughts and feelings, 2 times/day
Intervention Description
Participants are instructed to be mindful (pay attention) to their current thoughts and feelings and complete ecological momentary assessments of their current psychological stress states (e.g., stress appraisals, affect, perseverative cognitions, self-criticism, social connection)
Primary Outcome Measure Information:
Title
Acceptability of the intervention will be measured with an adapted version of the Treatment Acceptability Questionnaire (TAQ).
Description
The Treatment Acceptability Questionnaire (TAQ) is a six-item scale assessing whether participants view their assigned intervention as acceptable, ethical, and effective. Items are rated on a 7-point Likert scale (e.g., 1 "very unacceptable" to 7 "very acceptable), with a possible score range from 6 to 42. Higher scores indicate better treatment acceptability and positive perceptions of the treatment. A total mean score of at least 24 will indicate sufficient acceptability of the intervention.
Time Frame
Assessed at post-intervention, approximately 8 weeks from baseline
Title
Feasibility, as indicated by numbers of participants screened (completed web-based screener and phone screener), eligible based on web-based screener and phone screener, consented, randomized to treatment, and retained at follow-up.
Description
Feasibility outcomes will include: >70% of eligible participants (passed web-based and phone screener) will be consented, >70% of consented participants will pass further baseline screening procedures and will be randomized to treatment, >70% of participants who are randomized to treatment will be retained at follow-up. Reasons for ineligibility and drop out will also be assessed.
Time Frame
Anticipated study period of 12 months
Title
Adherence, as measured by the percentage of assigned and completed intervention group practices.
Description
Completion of at least 50% of assigned intervention group practices (Ecological Momentary Assessments for Mindful Awareness group; mindfulness practices for Mindful Activity group) is considered acceptable.
Time Frame
Baseline to follow-up, an anticipated 8 weeks
Secondary Outcome Measure Information:
Title
Change in depressive symptoms, as measured by the total score on the 9-item Patient Health Questionnaire (PHQ-9).
Description
The 9-item Patient Health Questionnaire (PHQ-9) has a total score scale range of 0 to 27, with higher values indicating more depressive symptoms.
Time Frame
Baseline to post-intervention, an anticipated 8 weeks

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
Self-representation of gender identity.
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: female sex and gender identity (to control for sex and gender differences in stress responses and health outcomes) age 30-50 (to examine intervention effects on health outcomes in midlife) ≥2 Adverse Childhood Experiences (to ensure exposure to early life adversity) mild depressive symptoms (to allow for outcome improvements: PHQ-9 ≥ 5) having a smartphone (to access app-based assessments/interventions) Exclusion Criteria: Non-English speaker or unable to provide informed consent Current regular mindfulness practice (exclude if >20 min/week) Major psychiatric condition, including psychosis/schizophrenia, bipolar disorder, post-traumatic stress disorder, eating disorders, alcohol/substance use, major depression (PHQ-9 ≥ 15), and self-harm or suicidal ideation Major medical conditions, including no history of coronary heart disease, diabetes, severe asthma or lung disease, autoimmune disorders, infectious disease, epilepsy, brain injury, endocrine disorders, diagnosis of cancer or chemotherapy or radiation in the past 10 years Free from medications known to affect the immune and endocrine systems with the exception of antidepressant medication and oral contraceptives Psychotherapy treatment permitted if stable (≥3 months) Current smoking and nicotine use Currently pregnant
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Stefanie E Mayer, PhD
Phone
7345450698
Email
stefanie.mayer@ucsf.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Lindsey Fox
Email
Lindsey.Fox@ucsf.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stefanie E Mayer, PhD
Organizational Affiliation
University of California, San Francisco
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of California, San Francisco
City
San Francisco
State/Province
California
ZIP/Postal Code
94118
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Stefanie E Mayer, PhD
Email
stefanie.mayer@ucsf.edu
First Name & Middle Initial & Last Name & Degree
Lindsey Fox
Email
Lindsey.Fox@ucsf.edu
First Name & Middle Initial & Last Name & Degree
Stefanie E Mayer, PhD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Examine the Effects of Mindfulness in Woman With a History of Child Adversity

We'll reach out to this number within 24 hrs